Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scope Capital Partners (commonly known as Scope) is a Nordic growth equity firm headquartered in Stockholm, Sweden. Founded in 2001, the firm specializes in investing in and partnering with high-growth companies across various sectors, with a significant focus on healthcare, medical technology, and technology-enabled services. Scope typically targets companies in the Nordic region that have proven business models and international expansion potential. Notable healthcare investments in their portfolio include Bonesupport, a developer of orthobiologic bone graft substitutes, and Zenicor, a medical technology company specializing in arrhythmia diagnostics. The firm provides both capital and strategic expertise to help its portfolio companies scale and achieve market leadership.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scope Capital Partners.